Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
BioArctic B | BIOAB | 10. jui 2024 | 231.20 | -2.69 |
BioGaia B | BIOGB | 10. jui 2024 | 124.30 | -0.88 |
BioInvent International | BINV | 10. jui 2024 | 35.30 | +0.57 |
Biosergen | BIOSGN | 10. jui 2024 | 0.34 | +5.85 |
Biovica International B | BIOVICB | 10. jui 2024 | 2.54 | +10.65 |
Calliditas Therapeutics | CALTX | 10. jui 2024 | 206.80 | -0.67 |
Camurus | CAMX | 10. jui 2024 | 588.00 | -1.84 |
Cantargia | CANTA | 10. jui 2024 | 4.59 | -3.20 |
Cereno Scientific B | CRNOB | 10. jui 2024 | 4.42 | -0.09 |
Chordate Medical Holding | CMH | 10. jui 2024 | 0.06 | +6.15 |
Chosa Oncology AB | CHOSA | 10. jui 2024 | 1.01 | -0.49 |
Cline Scientific B | CLINEB | 10. jui 2024 | 0.09 | +1.12 |
Coegin Pharma | COEGIN | 10. jui 2024 | 5.96 | -2.93 |
Combigene | COMBI | 10. jui 2024 | 3.28 | +2.50 |
Corline Biomedical | CLBIO | 10. jui 2024 | 10.90 | -0.91 |
Cyxone | CYXO | 10. jui 2024 | 0.13 | -7.80 |
DexTech Medical | DEX | 10. jui 2024 | 4.22 | +0.96 |
Diagonal Bio | DIABIO | 10. jui 2024 | 0.03 | -0.97 |
Diamyd Medical B | DMYDB | 10. jui 2024 | 14.38 | +11.65 |
Dicot Pharma AB | DICOT | 10. jui 2024 | 0.31 | +1.31 |
Double Bond Pharmaceutical B | DBPB | 10. jui 2024 | 0.49 | -8.21 |
Ectin Research | ECTINB | 10. jui 2024 | 0.76 | +17.97 |
Egetis Therapeutics | EGTX | 10. jui 2024 | 9.18 | +1.32 |
Elicera Therapeutics | ELIC | 10. jui 2024 | 1.31 | +2.34 |
Ellen | ELN | 10. jui 2024 | 1.37 | -2.14 |
Enorama Pharma | ERMA | 10. jui 2024 | 2.45 | 0.00 |
Enzymatica | ENZY | 10. jui 2024 | 2.88 | +2.13 |
EQL Pharma | EQL | 10. jui 2024 | 50.80 | -1.93 |
Eurocine Vaccines | EUCI | 10. jui 2024 | 0.03 | -12.43 |
ExpreS2ion Biotech Holding | EXPRS2 | 10. jui 2024 | 1.11 | -3.65 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.